Research and analysis

Return on investment tool: colorectal cancer

A tool to help local commissioners understand the economic case for early diagnosis of bowel cancer, colon cancer and rectal cancer.

Documents

Return on investment tool: colorectal cancer

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

How to use the return on investment tool

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Assessing the cost-effectiveness of improving early diagnosis of colorectal cancer

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The return on investment (ROI) tool brings together clinical commissioning group (CCG) data with research about the costs and long-term benefits of early diagnosis of colorectal cancer.

Local commissioners can:

  • see how their CCG is performing

  • calculate the difference that specific interventions could make to cost-effectiveness and patient outcomes in their local area

The report and user guide:

  • describe the most cost-effective local interventions, focusing on early diagnosis as well as other phases of the colorectal care pathway

  • show you how to use the ROI tool

If you have any questions or feedback about the tool, email healtheconomics@phe.gov.uk.

Updates to this page

Published 1 November 2016

Sign up for emails or print this page